Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD

被引:3
|
作者
Nag, Niharika [1 ]
Tripathi, Timir [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793022, India
[2] Indira Gandhi Natl Open Univ IGNOU, Reg Directors Office, Reg Ctr Kohima, Kohima 797001, India
来源
ACS CHEMICAL NEUROSCIENCE | 2022年 / 13卷 / 17期
关键词
Nucleocytoplasmic transport; amyotrophic lateral sclerosis; ALS/FTLD; Nup62; proteinopathy; TDP-43; FG-Nups; condensates; NUCLEOCYTOPLASMIC TRANSPORT; DISRUPTS;
D O I
10.1021/acschemneuro.2c00480
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nucleocytoplasmic transport (NCT) is impaired in C9-ALS/FTLD, a common genetically caused form of ALS and FTLD. The NCT is regulated by proteins called FG-nucleoporins (FG-Nups), with domains enriched in phenylalanine-glycine repeats. However, the relationship between FG-Nups and TDP-43, an RBP found to be mislocalized in ALS/FTLD patients, has not been defined. A recent study found that a critical protein, FG-Nup62, is mislocalized both in vivo and in vitro in diseased states. The mislocalized Nup62 was colocalized with TDP-43 in cytoplasmic inclusions and promoted its liquid-to-solid transition. The work highlights the involvement of Nup62 in the pathogenesis of ALS/FTLD and the interaction between Nup62 and TDP-43.
引用
收藏
页码:2544 / 2546
页数:3
相关论文
共 50 条
  • [21] Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP)
    Armstrong, Richard A.
    Cairns, Nigel J.
    NEUROLOGICAL SCIENCES, 2011, 32 (04) : 653 - 659
  • [22] TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
    Emma L. Scotter
    Han-Jou Chen
    Christopher E. Shaw
    Neurotherapeutics, 2015, 12 : 352 - 363
  • [23] The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
    Berning, Britt A.
    Walker, Adam K.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [24] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Lindsey R. Hayes
    Petr Kalab
    Neurotherapeutics, 2022, 19 : 1061 - 1084
  • [25] NOVEL IN VITRO AND IN VIVO MODELS OF ALS ASSOCIATED WITH TDP-43 PROTEINOPATHY
    Hewamadduma, C.
    Higgenbottom, C. A. A.
    Moens, C.
    Helde, K.
    Raman, R.
    Tennore, R.
    Grierson, A.
    Shaw, P. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03):
  • [26] TDP-43 and FUS in ALS/FTLD Will common pathways fit all?
    Buratti, Emanuele
    NEUROLOGY, 2011, 77 (17) : 1588 - 1589
  • [27] Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD
    Yamashita, Takenari
    Teramoto, Sayaka
    Kwak, Shin
    NEUROSCIENCE RESEARCH, 2016, 107 : 63 - 69
  • [28] TDP-43: a novel neurodegenerative proteinopathy
    Forman, Mark S.
    Trojanowski, John Q.
    Lee, Virginia M-Y
    CURRENT OPINION IN NEUROBIOLOGY, 2007, 17 (05) : 548 - 555
  • [29] The role of hyperphosphorylation in TDP-43 proteinopathy
    Pang-hsien, B.
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 : 44 - 45
  • [30] A Drosophila model for TDP-43 proteinopathy
    Li, Yan
    Ray, Payal
    Rao, Elizabeth J.
    Shi, Chen
    Guo, Weirui
    Chen, Xiaoping
    Woodruff, Elvin A., III
    Fushimi, Kazuo
    Wu, Jane Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (07) : 3169 - 3174